Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma

Journal of Biochemical and Molecular Toxicology

Volumn 31, Issue 7, 2017, Pages

  Wang, Yandan ^a   Cheng, Nan ^a   Luo, Junpeng ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

ANRIL; cisplatin; lncRNA; miR let 7a; nasopharyngeal carcinoma

Indexed keywords

ANTISENSE NON CODING RNA IN THE INK4 LOCUS; CISPLATIN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA LET-7A; UNCLASSIFIED DRUG; ANRIL LONG NON-CODING RNA, HUMAN; CYTOTOXIN; MIRNLET7 MICRORNA, HUMAN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; DOWN REGULATION; DRUG MECHANISM; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; UPREGULATION; BIOSYNTHESIS; CARCINOMA; DRUG EFFECTS; GENE EXPRESSION REGULATION; MALE; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; CYTOTOXINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; RNA, LONG NONCODING; RNA, NEOPLASM;

EID: 85010778084     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21904     Document Type: Article

References (39)

1. L. L. Tang, W. Q. Chen, W. Q. Xue, Y. Q. He, R. S. Zheng, Y. X. Zeng, W. H. Jia. Cancer Lett. 2016, 374(1), 22–30.
2. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, D. Forman. CA Cancer J. Clin. 2011, 61(2), 69–90.
3. A. Wu, K. Wu, J. Li, Y. Mo, Y. Lin, Y. Wang, X. Shen, S. Li, L. Li, Z. Yang. J. Transl. Med. 2015, 13, 105.
4. L. H. Cao, H. T. Li, W. Q. Lin, H. Y. Tan, L. Xie, Z. J. Zhong, J. H. Zhou. Sci. Rep. 2016, 6, 18706.
5. L. Zhang, Q. Y. Chen, H. Liu, L. Q. Tang, H. Q. Mai. Drug Des. Dev. Ther. 2013, 7, 37–52.
6. A. T. Chan, V. Gregoire, J. L. Lefebvre, L. Licitra, E. P. Hui, S. F. Leung, E. Felip. Ann. Oncol. 2012, 23(Suppl 7), vii83–85.
7. L. Li, M. Gu, B. You, S. Shi, Y. Shan, L. Bao, Y. You. Cancer Sci. 2016, 107(9), 1215–1222.
8. W. Zhao, J. Luo, S. Jiao. Sci. Rep. 2014, 4, 6591.
9. M. Meryet-Figuiere, B. Lambert, P. Gauduchon, N. Vigneron, E. Brotin, L. Poulain, C. Denoyelle. Oncotarget 2016, 7(28), 44719–44734.
10. C. Jin, Y. Zheng, Y. Huang, Y. Liu, L. Jia, Y. Zhou. Cell Biol. Int. 2016.
11. X. Du, M. D. Xu, Y. Wang, W. W. Weng, P. Wei, P. Qi, Q. Zhang, C. Tan, S. Ni, L. Dong and others. Clin. Cancer Res. 2016.
12. Y. Fan, B. Shen, M. Tan, X. Mu, Y. Qin, F. Zhang, Y. Liu. FEBS J. 2014, 281(7), 1750–1758.
13. S. Ren, G. Li, C. Liu, T. Cai, Z. Su, M. Wei, L. She, Y. Tian, Y. Qiu, X. Zhang and others. Oncol. Rep. 2016, 36(4), 1861–1867.
14. K. L. Yap, S. Li, A. M. Munoz-Cabello, S. Raguz, L. Zeng, S. Mujtaba, J. Gil, M. J. Walsh, M. M. Zhou. Mol. Cell 2010, 38(5), 662–674.
15. E. Pasmant, I. Laurendeau, D. Heron, M. Vidaud, D. Vidaud, I. Bieche. Cancer Res. 2007, 67(8), 3963–3969.
16. E. B. Zhang, R. Kong, D. D. Yin, L. H. You, M. Sun, L. Han, T. P. Xu, R. Xia, J. S. Yang, W. De and others. Oncotarget 2014, 5(8), 2276–2292.
17. Z. W. Zou, C. Ma, L. Medoro, L. Chen, B. Wang, R. Gupta, T. Liu, X. Z. Yang, T. T. Chen, R. Z. Wang and others. Oncotarget 2016.
18. D. P. Bartel. Cell 2009, 136(2), 215–233.
19. Y. Wang, X. Wang, J. Zhang, G. Sun, H. Luo, C. Kang, P. Pu, T. Jiang, N. Liu, Y. You. J. Neurooncol. 2012, 106(2), 217–224.
20. M. Zhao, R. Luo, Y. Liu, L. Gao, Z. Fu, Q. Fu, X. Luo, Y. Chen, X. Deng, Z. Liang and others. Nat. Commun. 2016, 7, 11309.
21. M. Liu, H. Xiusheng, X. Xiao, Y. Wang. Oncol Rep. 2016.
22. B. Shen, S. Yu, Y. Zhang, Y. Yuan, X. Li, J. Zhong, J. Feng. Onco Targets Ther. 2016, 9, 6009–6019.
23. Y. Shao, M. Ye, Q. Li, W. Sun, G. Ye, X. Zhang, Y. Yang, B. Xiao, J. Guo. Oncotarget 2016, 7(25), 37812–37824.
24. Y. Zhou, Q. S. Dai, S. C. Zhu, Y. H. Han, H. L. Han, B. Zhao, R. R. Gao, J. Zhang, J. Zhang. Biochem. J. 2016, 473(20), 3639–3654.
25. S. Liang, X. Peng, X. Li, P. Yang, L. Xie, Y. Li, C. Du, G. Zhang. Oncotarget 2015, 6(2), 1020–1030.
26. F. A. Karreth, P. P. Pandolfi. Cancer Discov. 2013, 3(10), 1113–1121.
27. B. B. Ma, V. W. Lui, E. P. Hui, C. P. Lau, K. Ho, M. H. Ng, S. H. Cheng, S. W. Tsao, A. T. Chan. Invest. New Drugs 2010, 28(4), 413–420.
28. P. Wang, Y. Xue, Y. Han, L. Lin, C. Wu, S. Xu, Z. Jiang, J. Xu, Q. Liu, X. Cao. Science 2014, 344(6181), 310–313.
29. F. A. Karreth, Y. Tay, D. Perna, U. Ala, S. M. Tan, A. G. Rust, G. DeNicola, K. A. Webster, D. Weiss, P. A. Perez-Mancera and others. Cell 2011, 147(2), 382–395.
30. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W. J. Haveman, P. P. Pandolfi. Nature 2010, 465(7301), 1033–1038.
31. H. Hirata, Y. Hinoda, V. Shahryari, G. Deng, K. Nakajima, Z. L. Tabatabai, N. Ishii, R. Dahiya. Cancer Res. 2015, 75(7), 1322–1331.
32. M. Sun, X. H. Liu, K. M. Wang, F. Q. Nie, R. Kong, J. S. Yang, R. Xia, T. P. Xu, F. Y. Jin, Z. J. Liu and others. Mol. Cancer 2014, 13, 68.
33. J. J. Zhao, S. Hao, L. L. Wang, C. Y. Hu, S. Zhang, L. J. Guo, G. Zhang, B. Gao, Y. Jiang, W. G. Tian and others. Oncotarget 2016.
34. J. J. Qiu, Y. Wang, Y. L. Liu, Y. Zhang, J. X. Ding, K. Q. Hua. Oncotarget 2016, 7(22), 32478–32492.
35. H. Zhu, X. Li, Y. Song, P. Zhang, Y. Xiao, Y. Xing. Biochem. Biophys. Res. Commun. 2015, 467(2), 223–228.
36. G. Guo, Q. Kang, X. Zhu, Q. Chen, X. Wang, Y. Chen, J. Ouyang, L. Zhang, H. Tan, R. Chen and others. Oncogene 2015, 34(14), 1768–1779.
37. M. Cesana, D. Cacchiarelli, I. Legnini, T. Santini, O. Sthandier, M. Chinappi, A. Tramontano, I. Bozzoni. Cell 2011, 147(2), 358–369.
38. R. Y. Liu, Z. Dong, J. Liu, J. Y. Yin, L. Zhou, X. Wu, Y. Yang, W. Mo, W. Huang, S. K. Khoo and others. Oncogene 2011, 30(48), 4814–4823.
39. W. G. Lan, D. H. Xu, C. Xu, C. L. Ding, F. L. Ning, Y. L. Zhou, L. B. Ma, C. M. Liu, X. Han. Oncol. Rep. 2016, 36(1), 263–270.